These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24948064)

  • 1. Interferon alpha and rapamycin inhibit the growth of carcinoid and medullary thyroid cancer in vitro.
    Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
    Pharmacol Rep; 2014 Aug; 66(4):624-9. PubMed ID: 24948064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
    Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
    Endokrynol Pol; 2013; 64(5):368-74. PubMed ID: 24186594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
    Grozinsky-Glasberg S; Rubinfeld H; Nordenberg Y; Gorshtein A; Praiss M; Kendler E; Feinmesser R; Grossman AB; Shimon I
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):87-94. PubMed ID: 19815051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M; Schally AV; Pfragner R; Malfertheiner MV; Modlin IM
    Cancer; 2008 Mar; 112(6):1404-14. PubMed ID: 18224665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells.
    Azzariti A; Porcelli L; Gatti G; Nicolin A; Paradiso A
    Biochem Pharmacol; 2008 Mar; 75(5):1035-44. PubMed ID: 18191814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic medullary thyroid carcinoma or calcitonin-secreting carcinoid tumor of lung? A diagnostic dilemma in a patient with lung mass and thyroid nodule.
    Vahidi S; Stewart J; Amin K; Racila E; Li F
    Diagn Cytopathol; 2018 Apr; 46(4):345-348. PubMed ID: 29124912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors.
    Moreno A; Akcakanat A; Munsell MF; Soni A; Yao JC; Meric-Bernstam F
    Endocr Relat Cancer; 2008 Mar; 15(1):257-66. PubMed ID: 18310292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro.
    Sacewicz M; Lawnicka H; Siejka A; Stepień T; Krupiński R; Komorowski J; Stepień H
    Cancer Lett; 2008 Sep; 268(1):120-8. PubMed ID: 18486324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
    Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
    Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
    Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
    Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.
    Pivonello C; Rousaki P; Negri M; Sarnataro M; Napolitano M; Marino FZ; Patalano R; De Martino MC; Sciammarella C; Faggiano A; Rocco G; Franco R; Kaltsas GA; Colao A; Pivonello R
    Endocrine; 2017 Jun; 56(3):603-620. PubMed ID: 27688013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.
    Kunnimalaiyaan M; Yan S; Wong F; Zhang YW; Chen H
    Surgery; 2005 Dec; 138(6):1137-42; discussion 1142. PubMed ID: 16360401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer.
    Li X; Tong LJ; Ding J; Meng LH
    Cancer Lett; 2014 Jan; 342(1):159-66. PubMed ID: 24018642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.
    Bertazza L; Barollo S; Radu CM; Cavedon E; Simioni P; Faggian D; Plebani M; Pelizzo MR; Rubin B; Boscaro M; Pezzani R; Mian C
    J Cell Mol Med; 2015 Sep; 19(9):2244-52. PubMed ID: 26081844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha: regulatory effects on cell cycle and angiogenesis.
    Rosewicz S; Detjen K; Scholz A; von Marschall Z
    Neuroendocrinology; 2004; 80 Suppl 1():85-93. PubMed ID: 15477724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin inhibits the invasive ability of thyroid cancer cells by down-regulating the expression of VEGF-C in vitro.
    Feng W; Jia S
    Cell Biochem Funct; 2012 Aug; 30(6):487-91. PubMed ID: 22447639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the multifaceted antitumor activity of axitinib in lung carcinoids.
    Oldani M; Cantone MC; Gaudenzi G; Carra S; Dicitore A; Saronni D; Borghi MO; Lombardi A; Caraglia M; Persani L; Vitale G
    Front Endocrinol (Lausanne); 2024; 15():1433707. PubMed ID: 39050569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Bodet-Milin C; Niaudet C; Saï-Maurel C; Moreau A; Faivre-Chauvet A; Thomare P; Deleris G; Estieu-Gionnet K; Bikfalvi A; Barbet J; Paris F
    J Nucl Med; 2010 Apr; 51(4):624-31. PubMed ID: 20351352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin inhibits cell growth of medullary thyroid carcinoma by reducing cell cycle progression into S phase.
    Tomoda C; Moatamed F; Naeim F; Hershman JM; Sugawara M
    Exp Biol Med (Maywood); 2008 Nov; 233(11):1433-40. PubMed ID: 18791128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.